|
|
Article: NIH AWARDS HIV GRANT TO ANTIGEN EXPRESS FOR DNA VACCINE.
- Article from:
- Biotech Business
- Article date:
- July 1, 2003
CopyrightCOPYRIGHT 2003 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antigen Express, Worcester, Mass. has been awarded a $357,000 NIH Small Business Innovative Research (SBIR) award that supports pre-clinical testing of a novel HIV DNA vaccine incorporating Antigen Express proprietary platform technology for boosting antigen-specific T-helper cell responses. The grant is provided by the NIAID (National Institute of Allergy and Infectious Diseases).
The grant funds pre-clinical studies for a priority use of this HIV DNA vaccine to induce potent immune responses capable of preventing HIV infection and eradicating HIV in infected individuals.
Antigen Express scientists have pioneered strategies for enhancing helper T-cell ...